肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
CANCER RESEARCH AND CLINIC
2010年
1期
41-43
,共3页
卢冬梅%邸志强%薛承岩%杜新生%杨林瀛
盧鼕梅%邸誌彊%薛承巖%杜新生%楊林瀛
로동매%저지강%설승암%두신생%양림영
肺肿瘤%肿瘤转移%肿瘤标记,生物学
肺腫瘤%腫瘤轉移%腫瘤標記,生物學
폐종류%종류전이%종류표기,생물학
Lung neoplasms%Neoplasm metastasis%Tumor makers,biological
目的 了解检测外周血液癌胚抗原mRNA(CEA mRNA)、细胞角蛋白19 mRNA(CK19mRNA)和端粒酶在监测肺癌血液转移中的应用价值.方法 外周血液标本应用反转录-套式-聚合酶链反应检测103例肺癌患者(肺癌组)、57例非癌性肺部疾病患者(非肿瘤组)及36例健康志愿者(健康组)CEA mRNA和CK19 mRNA,端粒重复序列扩增-微孔板杂交-酶联免疫分析检测端粒酶.结果 肺癌组血液三种肿瘤标志物的阳性率显著高于非肿瘤组和健康组(P<0.001),CEA mRNA和端粒酶的敏感度显著高于CK19 mRNA(P<0.01),TNM Ⅲ、Ⅳ期的阳性率显著高于Ⅰ期(P<0.05).结论 检测血液CEA mRNA、CK19 mRNA和端粒酶有助于发现肺癌血液扩散,其中CEA mRNA和端粒酶的价值高于CK19 mRNA,联合检测可进一步提高敏感度.
目的 瞭解檢測外週血液癌胚抗原mRNA(CEA mRNA)、細胞角蛋白19 mRNA(CK19mRNA)和耑粒酶在鑑測肺癌血液轉移中的應用價值.方法 外週血液標本應用反轉錄-套式-聚閤酶鏈反應檢測103例肺癌患者(肺癌組)、57例非癌性肺部疾病患者(非腫瘤組)及36例健康誌願者(健康組)CEA mRNA和CK19 mRNA,耑粒重複序列擴增-微孔闆雜交-酶聯免疫分析檢測耑粒酶.結果 肺癌組血液三種腫瘤標誌物的暘性率顯著高于非腫瘤組和健康組(P<0.001),CEA mRNA和耑粒酶的敏感度顯著高于CK19 mRNA(P<0.01),TNM Ⅲ、Ⅳ期的暘性率顯著高于Ⅰ期(P<0.05).結論 檢測血液CEA mRNA、CK19 mRNA和耑粒酶有助于髮現肺癌血液擴散,其中CEA mRNA和耑粒酶的價值高于CK19 mRNA,聯閤檢測可進一步提高敏感度.
목적 료해검측외주혈액암배항원mRNA(CEA mRNA)、세포각단백19 mRNA(CK19mRNA)화단립매재감측폐암혈액전이중적응용개치.방법 외주혈액표본응용반전록-투식-취합매련반응검측103례폐암환자(폐암조)、57례비암성폐부질병환자(비종류조)급36례건강지원자(건강조)CEA mRNA화CK19 mRNA,단립중복서렬확증-미공판잡교-매련면역분석검측단립매.결과 폐암조혈액삼충종류표지물적양성솔현저고우비종류조화건강조(P<0.001),CEA mRNA화단립매적민감도현저고우CK19 mRNA(P<0.01),TNM Ⅲ、Ⅳ기적양성솔현저고우Ⅰ기(P<0.05).결론 검측혈액CEA mRNA、CK19 mRNA화단립매유조우발현폐암혈액확산,기중CEA mRNA화단립매적개치고우CK19 mRNA,연합검측가진일보제고민감도.
Objective To understand the clinical value on the detection of carcinoembryonic antigen mRNA (CEA mRNA), cytokeratin 19 mRNA (CK19 mRNA) and telomerase in blood for the monitoring of blood metastasis of lung cancer. Methods CEA mRNA and CK19 mRNA were detected by reverse transcriptase-nested primers-polymerase chain reaction, telomerase was detected by telomeric repeat amplification protocol-hybridism-enzyme-linked immunosorbent assay in peripheral blood. Results The positive rates of the three tumor markers in lung cancer group were much higher than the non-tumor group and the health group (P<0.001). The sensibility of CEA mRNA and telomerase were much higher than CK19 mRNA (P<0.01). The positive rates of the markers in TNM stages Ⅲ and Ⅳ were much higher than in stages Ⅰ (P<0.05 to P<0.01). Conclusion It had high value that detecting CEA mRNA, CK19 mRNA and telomerase in peripheral blood on the discovery of blood metastasis of lung cancer. Among them, the clinical value of CEA mRNA and telomerase are higher than CK19 mRNA, and combined assay of the markers can improve the sensibility.